- Home
- NRXP vs STSS Comparison
NRXP vs STSS Comparison
Compare NRXP & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | STSS |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | 55 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 43.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | STSS |
|---|---|---|
| Price | $2.52 | $1.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 787.8K | 397.8K |
| Earning Date | 05-14-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $0.02 |
| 52 Week High | $3.84 | $18.23 |
Technical Indicators
Market Signals| Indicator | NRXP | STSS |
|---|---|---|
| Relative Strength Index (RSI) | 68.40 | 57.32 |
| Support Level | $2.28 | $1.66 |
| Resistance Level | $2.79 | $2.02 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 91.35 | 100.00 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.